SEC 13F Intelligence

Dupont Capital Management Corp / LLY

Dupont Capital Management Corp’s Eli Lilly & Co Position

Does Dupont Capital Management Corp own Eli Lilly & Co (LLY)? Yes16.9K shares worth $16M (+1.76% of its 13F portfolio) as of Q1 2026, down from 18.2K shares the prior filed quarter.

Position Value
$16M
Q1 2026
Shares
16.9K
% of Portfolio
+1.76%
Quarters Held
30
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $9MQ2 ’19: $5MQ3 ’19: $5MQ4 ’19: $2MQ4 ’19Q1 ’20: $7MQ2 ’20: $6MQ3 ’20: $3MQ4 ’20: $3MQ4 ’20Q1 ’21: $3MQ2 ’21: $3MQ3 ’21: $2MQ4 ’21: $7MQ4 ’21Q1 ’22: $9MQ2 ’22: $10MQ3 ’22: $5MQ4 ’22: $6MQ4 ’22Q1 ’23: $7MQ2 ’23: $12MQ3 ’23: $24MQ4 ’23: $15MQ4 ’23Q1 ’24: $20MQ2 ’24: $23MQ3 ’24: $17MQ4 ’24: $14MQ4 ’24Q1 ’25: $16MQ2 ’25: $14MQ3 ’25: $14MQ4 ’25: $20MQ4 ’25Q1 ’26: $16Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202616.9K$16M+1.76%
Q4 202518.2K$20M+2.21%
Q3 202518.2K$14M+1.44%
Q2 202518.2K$14M+1.52%
Q1 202519.9K$16M+1.82%
Q4 202418.6K$14M+1.34%
Q3 202418.6K$17M+1.38%
Q2 202425.3K$23M+1.99%
Q1 202425.3K$20M+1.63%
Q4 202325.3K$15M+1.29%
Q3 202345.0K$24M+2.11%
Q2 202325.1K$12M+0.58%
Q1 202320.1K$7M+0.33%
Q4 202216.9K$6M+0.29%
Q3 202216.1K$5M+0.31%
Q2 202230.1K$10M+0.46%
Q1 202232.1K$9M+0.37%
Q4 202126.7K$7M+0.26%
Q3 202110.7K$2M+0.08%
Q2 202113.9K$3M+0.08%
Q1 202113.5K$3M+0.06%
Q4 202017.7K$3M+0.06%
Q3 202020.8K$3M+0.07%
Q2 202039.1K$6M+0.14%
Q1 202049.9K$7M+0.16%
Q4 201917.4K$2M+0.05%
Q3 201941.2K$5M+0.11%
Q2 201946.9K$5M+0.12%
Q1 201969.7K$9M+0.21%
Q4 201874.5K$9M+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Dupont Capital Management Corp’s full portfolio or all institutional holders of LLY.